- All sections
- C - Chemistry; metallurgy
- C07D - Heterocyclic compounds
- C07D 213/82 - Amides; Imides in position 3
Patent holdings for IPC class C07D 213/82
Total number of patents in this class: 1051
10-year publication summary
|
109
|
100
|
99
|
76
|
75
|
65
|
76
|
54
|
60
|
14
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Bristol-myers Squibb Company | 5080 |
25 |
| F. Hoffmann-La Roche AG | 7958 |
25 |
| Syngenta Participations AG | 4970 |
24 |
| Takeda Pharmaceutical Company Limited | 2961 |
24 |
| Novartis AG | 11238 |
19 |
| Boehringer Ingelheim International GmbH | 4629 |
19 |
| Vertex Pharmaceuticals Incorporated | 1581 |
18 |
| Janssen Pharmaceutica N.V. | 3839 |
17 |
| AstraZeneca AB | 3042 |
15 |
| Genentech, Inc. | 3742 |
14 |
| Amgen Inc. | 3779 |
14 |
| BASF SE | 19740 |
13 |
| Bayer Cropscience AG | 2241 |
12 |
| The Johns Hopkins University | 5377 |
12 |
| Astellas Pharma Inc. | 1145 |
11 |
| Sumitomo Chemical Company, Limited | 8808 |
9 |
| Apotex Inc. | 197 |
9 |
| Daiichi Sankyo Company, Limited | 1829 |
9 |
| AstraZeneca UK Limited | 768 |
8 |
| The General Hospital Corporation | 4517 |
8 |
| Other owners | 746 |